Originally published in the June 2011 Tennessee Board of Pharmacy Newsletter
Effective April 7, 2011, tramadol, carisoprodol, and products containing tramadol or carisoprodol have been classified as Schedule IV controlled substances in the state of Tennessee pursuant to Tenn. Comp. R. & Regs. Rule 0940-06-01.04, http://state.tn.us/sos/rules_filings/01-08-11.pdf, as authorized under Tenn. Code Ann. §39-17-403.
As of April 7, 2011, tramadol, carisoprodol, and products containing tramadol or carisoprodol should have been included in the Controlled Substance Monitoring Database submissions. Pharmacists should have worked with their pharmacy prescription dispensing software vendors or information technology experts to update the information they are required to submit to the Controlled Substance Monitoring Database to include prescriptions for tramadol-containing products and carisoprodolcontaining products dispensed on or after April 7, 2011.
The Tennessee Board of Pharmacy advised that all pharmacists and prescribing practitioners read and follow the Drug Enforcement Administration (DEA) requirements for controlled substances before accepting or prescribing tramadol, carisoprodol, or any other product containing tramadol or carisoprodol.
The Tennessee Board of Pharmacy also advised that all pharmacies and prescribing practitioners should have taken an inventory of their current stock of tramadol, carisoprodol, and other products which contain tramadol or carisoprodol on April 7, 2011.